Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armando L Morera-Fumero

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|May 24, 2013
Role of melatonin in schizophreniaArmando L Morera-Fumero, Pedro Abreu-Gonzalez
Drug and Alcohol Dependence|May 16, 2020
Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic reviewArmando L Morera-Fumero, Lourdes Fernandez-Lopez, Pedro Abreu-Gonzalez
Psychiatry and Clinical Neurosciences|February 27, 2013
S100B and schizophreniaSilvia Yelmo-Cruz, Armando L Morera-Fumero, Pedro Abreu-González
Journal of Clinical Medicine|July 29, 2025
Clinical Personality Patterns in Alcohol Use Disorder: A Study Focused on Sex DifferencesArmando L Morera-Fumero, Maria Natividad García-Gómez, Alejandro Jiménez-Sosa
Actas Espanolas De Psiquiatria|July 25, 2023
Brain-Derived Neurotrophic Factor (BDNF) and First-Episode Psychosis. A longitudinal one-year prognosis studySilvia Yelmo-Cruz, Armando L Morera-Fumero, Sunil Lakhwani, et al.
Actas Espanolas De Psiquiatria|September 17, 2021
Acute paranoid schizophrenia relapsed inpatients present summer/ winter but not day/night changes in serum S100B concentrationsArmando L Morera-Fumero, Estefanía Díaz-Mesa, Pedro Abreu-González, et al.
Plos One|December 9, 2017
A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophreniaArmando L Morera-Fumero, Estefanía Díaz-Mesa, Pedro Abreu-Gonzalez, et al.
Journal of Psychiatric Research|March 26, 2013
Summer/winter changes in serum S100B protein concentration as a source of research varianceArmando L Morera-Fumero, Pedro Abreu-Gonzalez, Manuel Henry-Benitez, et al.
Acta Neuropsychiatrica|December 12, 2022
Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patientsArmando L Morera-Fumero, Estefania Diaz-Mesa, Lourdes Fernandez-Lopez, et al.
Psychiatry Research|January 28, 2017
Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day/night change as a marker of acute paranoid schizophrenia relapseArmando L Morera-Fumero, Estefanía Díaz-Mesa, Pedro Abreu-Gonzalez, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|May 24, 2013
Role of melatonin in schizophreniaArmando L Morera-Fumero, Pedro Abreu-Gonzalez
Drug and Alcohol Dependence|May 16, 2020
Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic reviewArmando L Morera-Fumero, Lourdes Fernandez-Lopez, Pedro Abreu-Gonzalez
Psychiatry and Clinical Neurosciences|February 27, 2013
S100B and schizophreniaSilvia Yelmo-Cruz, Armando L Morera-Fumero, Pedro Abreu-González
Journal of Clinical Medicine|July 29, 2025
Clinical Personality Patterns in Alcohol Use Disorder: A Study Focused on Sex DifferencesArmando L Morera-Fumero, Maria Natividad García-Gómez, Alejandro Jiménez-Sosa
Actas Espanolas De Psiquiatria|July 25, 2023
Brain-Derived Neurotrophic Factor (BDNF) and First-Episode Psychosis. A longitudinal one-year prognosis studySilvia Yelmo-Cruz, Armando L Morera-Fumero, Sunil Lakhwani, et al.
Actas Espanolas De Psiquiatria|September 17, 2021
Acute paranoid schizophrenia relapsed inpatients present summer/ winter but not day/night changes in serum S100B concentrationsArmando L Morera-Fumero, Estefanía Díaz-Mesa, Pedro Abreu-González, et al.
Plos One|December 9, 2017
A three-month longitudinal study of changes in day/night serum total antioxidant capacity in paranoid schizophreniaArmando L Morera-Fumero, Estefanía Díaz-Mesa, Pedro Abreu-Gonzalez, et al.
Journal of Psychiatric Research|March 26, 2013
Summer/winter changes in serum S100B protein concentration as a source of research varianceArmando L Morera-Fumero, Pedro Abreu-Gonzalez, Manuel Henry-Benitez, et al.
Acta Neuropsychiatrica|December 12, 2022
Serum s100b protein levels as a neuroinflammatory biomarker of acutely relapsed paranoid schizophrenia patientsArmando L Morera-Fumero, Estefania Diaz-Mesa, Lourdes Fernandez-Lopez, et al.
Psychiatry Research|January 28, 2017
Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day/night change as a marker of acute paranoid schizophrenia relapseArmando L Morera-Fumero, Estefanía Díaz-Mesa, Pedro Abreu-Gonzalez, et al.
Pageof 2